research communications
of 2-pentyloxybenzamide
aInstitute of Inorganic Chemistry, University of Hamburg, Hamburg, Germany, bDepartment of Chemical Engineering, United Arab Emirates University, AL Ain, Abu Dhabi, United Arab Emirates, and cDepartment of Chemistry, United Arab Emirates University, AL Ain, Abu Dhabi, United Arab Emirates
*Correspondence e-mail: thies@uaeu.ac.ae
In the title molecule, C12H17NO2, the amide NH2 group is oriented toward the pentyloxy substituent and an intramolecular N—H⋯O hydrogen bond is formed with the pentyloxy O atom. The benzene ring forms dihedral angles of 2.93 (2) and 5.60 (2)° with the amide group and the pentyloxy group mean planes, respectively. In the crystal, molecules are linked by pairs of N—H⋯O hydrogen bonds, forming inversion dimers with their molecular planes parallel, but at an offset of 0.45 (1) Å to each other. These dimers are ordered into two types of symmetry-related columns extended along the a axis, with the mean plane of one set of dimers in a column approximately parallel to (121) and the other in a column approximately parallel to (1-21). The two planes form a dihedral angle of 85.31 (2)°, and are linked via C—H⋯O hydrogen bonds and C—H⋯π interactions, forming a three-dimensional framework structure.
Keywords: crystal structure; 2-alkoxybenzamide; hydrogen bonding..
CCDC reference: 1024316
1. Chemical context
2-Alkoxybenzamide moieties can be found as structural units in medicinally active compounds, such in dopamine (DA) receptor antagonists (van de Waterbeemd & Testa, 1983). Typically such components are Sulpiride®, Metoclopramide® and Tiapride®. Other substituted 2-alkoxybenzamides have been found to be antagonists of chemotherapy-induced nausea (Monkovic et al., 1988). Also, 2-alkoxybenzamides have been proposed as agonists of the α7 nicotinic receptor (Bodnar et al., 2005) and as neuroleptic compounds (Florvall & Oegren, 1982). 2-Ethoxybenzamide, under the name ethenzamide, is a commonly used analgesicum (Darias et al., 1992).
In our efforts to use 2-alkoxybenzamides as components in et al., 2012), we prepared the title compound, 2-pentyloxybenzamide, and report herein on its 2-Pentyloxybenzamide was first studied for its antipyretic and analgesic properties (Bavin et al., 1952; Macrae & Seymour, 1956). Afterwards, it was found to have antifungal activity and to be useful in the treatment of dermatomycosis (Simmonite & Tattersall, 1962; Coates et al., 1957). Under the name pentalamide, it is still used as an ingredient in antifungal agents for topical use.
formation (Aitipamula2. Structural commentary
In the title molecule, Fig. 1, the benzene ring is nearly coplanar with the amide group [C6—C1—C7—O1 = −2.48 (18)°] and the pentyloxy group [C3—C2—O2—C8 = 0.37 (18)°]. The amide NH2 group is oriented towards the ether group allowing for an intramolecular hydrogen bond (N1—H1B⋯O2; Fig. 1 and Table 1). The latter is also present in analogous compounds, such as 3-hydroxy-2-methoxybenzamide (Wilbrand et al., 2012), 2-propoxybenzamide (Al Jasem et al., 2012) and 2-(prop-2-enyloxy)benzamide (Bugenhagen et al., 2012). 2-Ethoxybenzamide is the only studied 2-alkoxybenzamide that does not exhibit an intramolecular hydrogen bond in the single component crystal (Pagola & Stephens, 2009). However, it shows a similar conformation to the other 2-alkoxybenzamides in the form with thiourea (Moribe et al., 2004), and with salicylic acid (Back et al., 2012).
3. Supramolecular features
In the crystal, molecules are linked by pairs of N-H⋯O (N1—H1A⋯O1) hydrogen bonds forming inversion dimers (Fig. 2 and Table 1). These dimers form a nested network of molecules, made of two layers, (121) and (11), which form an angle of 85.31 (2)° between their planes (Fig. 3). The dimers in the layers are linked by C—H⋯O (C4—H4⋯O1) hydrogen bonds and C—H⋯π interactions, forming a three-dimensional framework (Fig. 3 and Table 1). Within two parallel layers, pairs of molecules lie with an offset to each other without any noticeable, direct interaction between them; the parallel layers are at a distance of 3.81 (3) Å from each other. Along the a axis the pairs are ordered in two symmetry-related columns. The plane of the benzene ring (C1–C6) of the 2-pentyloxybenzamide forms an angle of 25.29 (2)° with the column axis.
4. Database survey
From a database survey (Cambridge Structural Database, Version 5.35, last update May 2014; Allen, 2002), the following were picked as relevant comparable structures: 3-hydroxy-2-methoxybenzamide (Wilbrand et al., 2012), 2-methoxybenzamide (Moribe et al., 2006), 2-ethoxybenzamide (Pagola & Stephens, 2009; Back et al., 2012), 2-propoxybenzamide (Al Jasem et al., 2012) and 2-(prop-2-enyloxy)benzamide (Bugenhagen et al., 2012). For 2-propoxybenzamide, a homologue of the title compound, a similar formation of inversion-related molecular pairs in the crystal was reported, hence the two compounds exhibit a similar packing. The noticeable difference between the two compounds is the larger dihedral angle between the carboxamide group and the benzene ring in 2-propoxybenzamide, 12.41 (2)° compared to 3.30 (15)° in the title compound, 2-pentyloxybenzamide. Also, the parallel layers of molecules in the title compound are further apart [separated by 3.81 (3) Å] than is found for a similar packing of 2-propoxybenzamide [3.69 (2) Å]. Similarly, inversion-related pairs of molecules are formed by intermolecular (amide–amide) hydrogen bonding in 2-ethoxybenzamide and 3-hydroxy-2-methoxybenzamide. As 2-ethoxybenzamide exhibits no intramolecular hydrogen bonding, the freed acceptor–donor sites are used for additional intermolecular hydrogen bonding with the adjacent molecule.
In contrast, in 2-methoxybenzamide and in 2-(prop-2-enyloxy)benzamide the intermolecular N—H⋯O hydrogen bonds involving the amide groups do not lead to pair formation but generate C(4) and R32(7) motifs.
5. Synthesis and crystallization
The preparation of the title compound follows a Williamson ether synthesis using DMSO as solvent, analogous to a general procedure (Johnstone & Rose, 1979): To powdered KOH (1.12 g, 20.0 mmol) in DMSO (18 ml) was added salicylamide (1.37 g, 10.0 mmol), and the resulting mixture was stirred for 10 min. at rt. Then, n-amyl iodide (4.2 g, mmol, 21.2 mmol) was added dropwise. The solution was stirred for 12 h at rt. It was then poured into water (200 ml) and extracted with chloroform (3 × 75 ml). The organic phase was dried over anhydrous MgSO4, concentrated in vacuo, and the residue was subjected to on silica gel (CHCl3/MtBE/hexane v/v/v 1:1:1) to give the title compound (1.55 g, 75%) as colourless crystals (m.p. 362 K). IR (KBr, cm−1) νmax 3434, 3168, 2948, 2868, 1664, 1593, 1387, 1232, 1164, 1018, 832, 788, 765, 575; 1H NMR (400 MHz, CDCl3, δH) 0.93 (3H, t, 3J = 7.2 Hz, CH3), 1.38–1.48 (4H, m), 1.84–1.89 (2H, m), 4.11 (2H, d, 3J = 6.4 Hz); 6.03 (1H, bs, NH), 6.96 (1H, d, 3J = 8.4 Hz), 7.03–7.07 (1H, m), 7.42–7.46 (1H, m), 7.85 (1H, bs, NH), 8.20 (1H, dd, 3J = 7.6 Hz, 4J = 2.0 Hz), 13C NMR (100.5 MHz, CDCl3, δC) 14.0 (CH3), 22.4 (CH2), 28.2 (CH2), 28.9 (CH2), 69.1 (OCH2), 112.2 (CH), 120.7 (Cquat), 121.0 (CH), 132.5 (CH), 133.3 (Cquat), 157.4 (Cquat), 167.2 (Cquat, CO).
6. Refinement
Crystal data, data collection and structure . All C-bound H atoms were placed in calculated positions and refined as riding atoms: C—H distances of 0.95 − 1.00 Å with Uiso(H) = xUeq(C), where x = 1.5 for methyl and = 1.2 for other H-atoms. The N-bound H atoms were located in a difference electron-density map and freely refined.
details are summarized in Table 2
|
Supporting information
CCDC reference: 1024316
10.1107/S1600536814020571/su2779sup1.cif
contains datablock I. DOI:Structure factors: contains datablock I. DOI: 10.1107/S1600536814020571/su2779Isup2.hkl
Supporting information file. DOI: 10.1107/S1600536814020571/su2779Isup3.cml
2-Alkoxybenzamide moieties can be found as structural units in medicinally active compounds, such in dopamine (DA) receptor antagonists (van de Waterbeemd & Testa, 1983). Typical such components are Sulpiride®, Metoclopramide® and Tiapride®. Other substituted 2-alkoxybenzamides have been found to be antagonists of chemotherapy-induced nausea (Monkovic et al., 1988). Also, 2-alkoxybenzamides have been proposed as agonists of the α7 nicotinic receptor (Bodnar et al., 2005) and as neuroleptic compounds (Florvall & Oegren, 1982). 2-Ethoxybenzamide, under the name ethenzamide, is a commonly used analgesicum (Darias et al., 1992). In our efforts to use 2-alkoxybenzamides as components in formation (Aitipamula et al., 2012), we prepared the title compound, 2-pentyloxybenzamide, and report herein on its 2-Pentyloxybenzamide was first studied for its antipyretic and analgesic properties (Bavin et al., 1952; Macrae & Seymour, 1956). Afterwards, it was found to have antifungal activity and to be useful in the treatment of dermatomycosis (Simmonite & Tattersall, 1962; Coates et al., 1957). Under the name pentalamide, it is still used as an ingredient in antifungal agents for topical use.
In the title molecule, Fig. 1, the benzene ring is nearly coplanar with the amide group [C6—C1—C7—O1 = -2.48 (18)°] and the pentyloxy group [C3—C2—O2—C8 = 0.37 (18)°]. The amide NH2 group is oriented towards the ether group allowing for an intramolecular hydrogen bond (N1—H1B···O2; Fig. 1 and Table 1). The latter is also present in analogous compounds, such as 3-hydroxy-2-methoxybenzamide (Wilbrand et al., 2012), 2-propoxybenzamide (Al Jasem et al., 2012) and 2-(prop-2-enyloxy)benzamide (Bugenhagen et al., 2012). 2-Ethoxybenzamide is the only studied 2-alkoxybenzamide that does not exhibit an intramolecular hydrogen bond in the single component crystal (Pagola & Stephens, 2009). However, it shows a similar conformation to the other 2-alkoxybenzamides in the
form with thiourea (Moribe et al., 2004), and with salicylic acid (Back et al., 2012).In the crystal, molecules are linked by pairs of N—H···O (N1—H1A···O1) hydrogen bonds forming inversion dimers (Fig. 2 and Table 1). These dimers form a nested network of molecules, made of two layers, (121) and (121), which form an angle of 85.31 (2)° between their planes (Fig. 3). The dimers in the layers are linked by C—H···O (C4—H4···O1) hydrogen bonds and C—H···π interactions, forming a three-dimensional framework (Fig. 3 and Table 1). Within two parallel layers, pairs of molecules lie with an offset to each other without any noticeable, direct interaction between them; the parallel layers are at a distance of 3.81 (3) Å from each other. Along the a axis the pairs are ordered in two symmetry-related columns. The plane of the benzene ring (C1–C6) of the 2-pentyloxybenzamide forms an angle of 25.29 (2)° with the column axis.
From a database survey (Cambridge Structural Database, Version 5.35, last update May 2014; Allen, 2002), the following were picked as relevant comparable structures: 3-hydroxy-2-methoxybenzamide (Wilbrand et al., 2012), 2-methoxybenzamide (Moribe et al., 2006), 2-ethoxybenzamide (Pagola & Stephens, 2009; Back et al., 2012), 2-propoxybenzamide (Al Jasem et al., 2012) and 2-(prop-2-enyloxy)benzamide (Bugenhagen et al., 2012). For 2-propoxybenzamide, a homologue of the title compound, a similar formation of inversion-related molecular pairs in the crystal was reported, hence the two compounds exhibit a similar packing. The noticeable difference between the two compounds is the larger dihedral angle between the carboxamide group and the benzene ring in 2-propoxybenzamide, 12.41 (2)° compared to 3.30 (15)° in the title compound, 2-pentyloxybenzamide. Also, the parallel layers of molecules in the title compound are further apart [separated by 3.81 (3) Å] than is found for a similar packing of 2-propoxybenzamide [3.69 (2) Å]. Similarly, inversion-related pairs of molecules are formed by intermolecular (amide–amide) hydrogen bonding in 2-ethoxybenzamide and 3-hydroxy-2-methoxybenzamide. As 2-ethoxybenzamide exhibits no intramolecular hydrogen bonding, the freed acceptor–donor sites are used for additional intermolecular hydrogen bonding with the adjacent molecule.
In contrast, in 2-methoxybenzamide and in 2-(prop-2-enyloxy)benzamide the intermolecular N—H···O hydrogen bonds involving the amide groups do not lead to pair formation but generate C(4) and R23(7) motifs.
The preparation of the title compound follows a Williamson ether synthesis using DMSO as solvent, analogous to a general procedure (Johnstone & Rose, 1979): To powdered KOH (1.12 g, 20.0 mmol) in DMSO (18 ml) was added salicylamide (1.37 g, 10.0 mmol), and the resulting mixture was stirred for 10 min. at rt. Then, n-amyl iodide (4.2 g, mmol, 21.2 mmol) was added dropwise. The solution was stirred for 12 h at rt. It was then poured into water (200 ml) and extracted with chloroform (3 × 75 ml). The organic phase was dried over anhydrous MgSO4, concentrated in vacuo, and the residue was subjected to νmax 3434, 3168, 2948, 2868, 1664, 1593, 1387, 1232, 1164, 1018, 832, 788, 765, 575; 1H NMR (400 MHz, CDCl3, δH ) 0.93 (3H, t, 3J = 7.2 Hz, CH3), 1.38–1.48 (4H, m), 1.84–1.89 (2H, m), 4.11 (2H, d, 3J = 6.4 Hz); 6.03 (1H, bs, NH), 6.96 (1H, d, 3J = 8.4 Hz), 7.03–7.07 (1H, m), 7.42–7.46 (1H, m), 7.85 (1H, bs, NH), 8.20 (1H, dd, 3J = 7.6 Hz, 4J = 2.0 Hz), 13C NMR (100.5 MHz, CDCl3, δC) 14.0 (CH3), 22.4 (CH2), 28.2 (CH2), 28.9 (CH2), 69.1 (OCH2), 112.2 (CH), 120.7 (Cquat), 121.0 (CH), 132.5 (CH), 133.3 (Cquat), 157.4 (Cquat), 167.2 (Cquat, CO).
on silica gel (CHCl3/MtBE/hexane v/v/v 1:1:1) to give the title compound (1.55 g, 75%) as colourless crystals (m.p. 362 K). IR (KBr, cm-1)Crystal data, data collection and structure
details are summarized in Table 2. All C-bound H atoms were placed in calculated positions and refined as riding atoms: C—H distances of 0.95 - 1.00 Å with Uiso(H) = xUeq(C), where x = 1.5 for methyl and = 1.2 for other H-atoms. The N-bound H atoms were located in a difference electron-density map and freely refined.Data collection: CrysAlis PRO (Agilent, 2012); cell
CrysAlis PRO (Agilent, 2012); data reduction: CrysAlis PRO (Agilent, 2012); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) within OLEX2 (Dolomanov et al., 2009); molecular graphics: PLATON (Spek, 2009) and Mercury (Macrae et al., 2008); software used to prepare material for publication: SHELXL97 (Sheldrick, 2008) and PLATON (Spek, 2009).Fig. 1. A view of the molecular structure of the title molecule, with atom labelling. Displacement ellipsoids are shown at the 50% probability level. The intramolecular N—H···O hydrogen bond is shown as a green dashed line (see Table 1 for details). | |
Fig. 2. A partial view of the crystal packing of the title compound. The hydrogen bonds are shown as green dashed lines [see Table 1 for details; symmetry codes: (i) -x+1, y+1/2, -z+1/2; (ii) x, y, z; (iii) x, -y+1/2, z+1/2; (iv) -x, y-1/2, -z+1/2] | |
Fig. 3. A view of the crystal network formed by the layers of inversion dimers in the planes (121) in red, and (121) in blue. The hydrogen bonds are shown as green dashed lines (see Table 1 for details; H atoms not involved in hydrogen bonding have been omitted for clarity). |
C12H17NO2 | F(000) = 448 |
Mr = 207.27 | Dx = 1.182 Mg m−3 |
Monoclinic, P21/c | Cu Kα radiation, λ = 1.5418 Å |
a = 8.1830 (2) Å | Cell parameters from 2743 reflections |
b = 11.2706 (2) Å | θ = 3.9–73.1° |
c = 14.5386 (4) Å | µ = 0.64 mm−1 |
β = 119.696 (2)° | T = 100 K |
V = 1164.76 (5) Å3 | Block, colourless |
Z = 4 | 0.25 × 0.19 × 0.10 mm |
SuperNova, Dual, Cu at zero, Atlas diffractometer | 2268 independent reflections |
Radiation source: SuperNova (Cu) X-ray Source | 1900 reflections with I > 2σ(I) |
Mirror monochromator | Rint = 0.022 |
Detector resolution: 10.4127 pixels mm-1 | θmax = 73.3°, θmin = 5.3° |
ω scans | h = −10→5 |
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2012) | k = −13→14 |
Tmin = 0.854, Tmax = 1.000 | l = −16→18 |
6112 measured reflections |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.041 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.115 | H atoms treated by a mixture of independent and constrained refinement |
S = 1.03 | w = 1/[σ2(Fo2) + (0.0645P)2 + 0.2593P] where P = (Fo2 + 2Fc2)/3 |
2268 reflections | (Δ/σ)max < 0.001 |
145 parameters | Δρmax = 0.19 e Å−3 |
0 restraints | Δρmin = −0.22 e Å−3 |
C12H17NO2 | V = 1164.76 (5) Å3 |
Mr = 207.27 | Z = 4 |
Monoclinic, P21/c | Cu Kα radiation |
a = 8.1830 (2) Å | µ = 0.64 mm−1 |
b = 11.2706 (2) Å | T = 100 K |
c = 14.5386 (4) Å | 0.25 × 0.19 × 0.10 mm |
β = 119.696 (2)° |
SuperNova, Dual, Cu at zero, Atlas diffractometer | 2268 independent reflections |
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2012) | 1900 reflections with I > 2σ(I) |
Tmin = 0.854, Tmax = 1.000 | Rint = 0.022 |
6112 measured reflections |
R[F2 > 2σ(F2)] = 0.041 | 0 restraints |
wR(F2) = 0.115 | H atoms treated by a mixture of independent and constrained refinement |
S = 1.03 | Δρmax = 0.19 e Å−3 |
2268 reflections | Δρmin = −0.22 e Å−3 |
145 parameters |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
C1 | 0.25614 (18) | 0.29076 (11) | 0.20599 (10) | 0.0233 (3) | |
C10 | −0.14119 (19) | 0.33945 (13) | 0.46481 (11) | 0.0269 (3) | |
C11 | −0.29380 (19) | 0.41079 (13) | 0.47067 (11) | 0.0294 (3) | |
C12 | −0.3051 (2) | 0.37915 (16) | 0.56955 (12) | 0.0389 (4) | |
C2 | 0.21475 (18) | 0.25854 (12) | 0.28594 (10) | 0.0240 (3) | |
C3 | 0.31443 (19) | 0.16670 (12) | 0.35597 (11) | 0.0279 (3) | |
C4 | 0.45350 (19) | 0.10654 (13) | 0.34698 (11) | 0.0303 (3) | |
C5 | 0.49609 (19) | 0.13709 (13) | 0.26885 (11) | 0.0301 (3) | |
C6 | 0.39777 (18) | 0.22849 (12) | 0.19968 (10) | 0.0266 (3) | |
C7 | 0.15680 (18) | 0.38484 (11) | 0.12366 (10) | 0.0232 (3) | |
C8 | 0.03619 (19) | 0.28821 (12) | 0.37434 (10) | 0.0263 (3) | |
C9 | −0.11424 (18) | 0.36885 (12) | 0.37063 (10) | 0.0256 (3) | |
H10A | −0.1714 | 0.2558 | 0.4618 | 0.032* | |
H10B | −0.0229 | 0.3526 | 0.5295 | 0.032* | |
H11A | −0.4142 | 0.3950 | 0.4082 | 0.035* | |
H11B | −0.2672 | 0.4948 | 0.4717 | 0.035* | |
H12A | −0.3329 | 0.2962 | 0.5683 | 0.058* | |
H12B | −0.4027 | 0.4250 | 0.5710 | 0.058* | |
H12C | −0.1869 | 0.3963 | 0.6315 | 0.058* | |
H1A | −0.056 (2) | 0.4934 (17) | 0.0658 (14) | 0.042 (5)* | |
H1B | −0.021 (2) | 0.4242 (16) | 0.1713 (14) | 0.041 (5)* | |
H3 | 0.2873 | 0.1458 | 0.4089 | 0.033* | |
H4 | 0.5188 | 0.0452 | 0.3937 | 0.036* | |
H5 | 0.5896 | 0.0967 | 0.2630 | 0.036* | |
H6 | 0.4270 | 0.2490 | 0.1475 | 0.032* | |
H8A | 0.1495 | 0.2950 | 0.4427 | 0.032* | |
H8B | −0.0062 | 0.2065 | 0.3650 | 0.032* | |
H9A | −0.2313 | 0.3570 | 0.3049 | 0.031* | |
H9B | −0.0767 | 0.4511 | 0.3742 | 0.031* | |
N1 | 0.01348 (16) | 0.44361 (11) | 0.12198 (9) | 0.0282 (3) | |
O1 | 0.20767 (12) | 0.40558 (9) | 0.05777 (7) | 0.0264 (2) | |
O2 | 0.07616 (13) | 0.32058 (8) | 0.29182 (7) | 0.0271 (2) |
U11 | U22 | U33 | U12 | U13 | U23 | |
O1 | 0.0293 (5) | 0.0312 (5) | 0.0239 (5) | −0.0023 (4) | 0.0171 (4) | 0.0000 (4) |
O2 | 0.0312 (5) | 0.0313 (5) | 0.0271 (5) | 0.0063 (4) | 0.0207 (4) | 0.0059 (4) |
N1 | 0.0343 (6) | 0.0299 (6) | 0.0271 (6) | 0.0063 (5) | 0.0204 (5) | 0.0060 (5) |
C1 | 0.0233 (6) | 0.0263 (6) | 0.0213 (6) | −0.0034 (5) | 0.0116 (5) | −0.0028 (5) |
C2 | 0.0227 (6) | 0.0269 (7) | 0.0250 (6) | −0.0002 (5) | 0.0139 (5) | −0.0021 (5) |
C3 | 0.0293 (7) | 0.0316 (7) | 0.0266 (7) | 0.0015 (5) | 0.0168 (6) | 0.0028 (5) |
C4 | 0.0302 (7) | 0.0313 (7) | 0.0300 (7) | 0.0060 (6) | 0.0153 (6) | 0.0045 (6) |
C5 | 0.0279 (7) | 0.0347 (8) | 0.0309 (7) | 0.0044 (6) | 0.0169 (6) | −0.0018 (6) |
C6 | 0.0259 (7) | 0.0331 (7) | 0.0244 (6) | −0.0013 (5) | 0.0153 (6) | −0.0028 (5) |
C7 | 0.0252 (7) | 0.0244 (6) | 0.0224 (6) | −0.0053 (5) | 0.0135 (5) | −0.0046 (5) |
C8 | 0.0303 (7) | 0.0300 (7) | 0.0250 (6) | 0.0035 (5) | 0.0186 (6) | 0.0055 (5) |
C9 | 0.0260 (7) | 0.0296 (7) | 0.0247 (6) | 0.0022 (5) | 0.0152 (5) | 0.0034 (5) |
C10 | 0.0281 (7) | 0.0318 (7) | 0.0259 (7) | 0.0031 (6) | 0.0173 (6) | 0.0039 (5) |
C11 | 0.0290 (7) | 0.0357 (7) | 0.0284 (7) | 0.0037 (6) | 0.0180 (6) | 0.0032 (6) |
C12 | 0.0405 (9) | 0.0513 (10) | 0.0375 (8) | 0.0100 (7) | 0.0288 (7) | 0.0064 (7) |
O1—C7 | 1.2412 (15) | C6—H6 | 0.9300 |
O2—C2 | 1.3706 (15) | C8—H8A | 0.9700 |
O2—C8 | 1.4381 (14) | C8—H8B | 0.9700 |
N1—C7 | 1.3366 (17) | C8—C9 | 1.5095 (18) |
N1—H1A | 0.919 (19) | C9—H9A | 0.9700 |
N1—H1B | 0.915 (17) | C9—H9B | 0.9700 |
C1—C2 | 1.4099 (17) | C9—C10 | 1.5272 (17) |
C1—C6 | 1.3962 (18) | C10—H10A | 0.9700 |
C1—C7 | 1.5013 (18) | C10—H10B | 0.9700 |
C2—C3 | 1.3966 (19) | C10—C11 | 1.5227 (18) |
C3—H3 | 0.9300 | C11—H11A | 0.9700 |
C3—C4 | 1.3853 (19) | C11—H11B | 0.9700 |
C4—H4 | 0.9300 | C11—C12 | 1.5278 (18) |
C4—C5 | 1.3866 (19) | C12—H12A | 0.9600 |
C5—H5 | 0.9300 | C12—H12B | 0.9600 |
C5—C6 | 1.385 (2) | C12—H12C | 0.9600 |
C1—C6—H6 | 119.0 | C6—C1—C7 | 116.23 (11) |
C10—C11—C12 | 111.28 (12) | C6—C1—C2 | 118.09 (12) |
C10—C11—H11B | 109.4 | C7—N1—H1B | 118.2 (11) |
C10—C11—H11A | 109.4 | C7—N1—H1A | 118.0 (10) |
C10—C9—H9B | 110.0 | C8—C9—C10 | 108.35 (11) |
C10—C9—H9A | 110.0 | C8—C9—H9B | 110.0 |
C11—C12—H12C | 109.5 | C8—C9—H9A | 110.0 |
C11—C12—H12B | 109.5 | C9—C10—H10B | 108.5 |
C11—C12—H12A | 109.5 | C9—C10—H10A | 108.5 |
C11—C10—H10B | 108.5 | C9—C8—H8B | 109.7 |
C11—C10—H10A | 108.5 | C9—C8—H8A | 109.7 |
C11—C10—C9 | 114.98 (11) | H10A—C10—H10B | 107.5 |
C12—C11—H11B | 109.4 | H11A—C11—H11B | 108.0 |
C12—C11—H11A | 109.4 | H12A—C12—H12C | 109.5 |
C2—C3—H3 | 119.9 | H12A—C12—H12B | 109.5 |
C2—C1—C7 | 125.65 (12) | H12B—C12—H12C | 109.5 |
C2—O2—C8 | 117.38 (10) | H1A—N1—H1B | 123.2 (14) |
C3—C4—C5 | 120.48 (13) | H8A—C8—H8B | 108.2 |
C3—C4—H4 | 119.8 | H9A—C9—H9B | 108.4 |
C3—C2—C1 | 119.99 (12) | N1—C7—C1 | 119.22 (11) |
C4—C5—H5 | 120.4 | O1—C7—C1 | 119.48 (11) |
C4—C3—H3 | 119.9 | O1—C7—N1 | 121.29 (12) |
C4—C3—C2 | 120.29 (12) | O2—C8—C9 | 109.63 (10) |
C5—C6—H6 | 119.0 | O2—C8—H8B | 109.7 |
C5—C6—C1 | 121.92 (12) | O2—C8—H8A | 109.7 |
C5—C4—H4 | 119.8 | O2—C2—C3 | 122.35 (11) |
C6—C5—H5 | 120.4 | O2—C2—C1 | 117.66 (11) |
C6—C5—C4 | 119.22 (12) | ||
C1—C2—C3—C4 | −0.3 (2) | C6—C1—C2—O2 | 179.67 (11) |
C2—C3—C4—C5 | 0.3 (2) | C7—C1—C6—C5 | −177.98 (12) |
C2—C1—C7—N1 | −1.4 (2) | C7—C1—C2—C3 | 178.07 (12) |
C2—C1—C7—O1 | 179.44 (12) | C7—C1—C2—O2 | −2.27 (19) |
C2—C1—C6—C5 | 0.3 (2) | C8—C9—C10—C11 | −178.10 (12) |
C2—O2—C8—C9 | 177.89 (11) | C8—O2—C2—C3 | 0.37 (18) |
C3—C4—C5—C6 | −0.1 (2) | C8—O2—C2—C1 | −179.28 (11) |
C4—C5—C6—C1 | −0.2 (2) | C9—C10—C11—C12 | −177.64 (12) |
C6—C1—C7—N1 | 176.66 (12) | O2—C8—C9—C10 | −175.11 (10) |
C6—C1—C7—O1 | −2.48 (18) | O2—C2—C3—C4 | −179.95 (12) |
C6—C1—C2—C3 | 0.02 (19) |
Cg1 is the centroid of the C1–C6 benzene ring. |
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1B···O2 | 0.915 (17) | 1.921 (18) | 2.6510 (15) | 135.4 (15) |
N1—H1A···O1i | 0.919 (19) | 1.964 (19) | 2.8824 (15) | 177.8 (17) |
C3—H3···O1ii | 0.93 | 2.62 | 3.546 (2) | 178 |
C4—H4···O1iii | 0.93 | 2.53 | 3.306 (2) | 141 |
C11—H11A···Cg1iv | 0.97 | 2.90 | 3.7283 (16) | 141 |
Symmetry codes: (i) −x, −y+1, −z; (ii) x, −y+1/2, z+1/2; (iii) −x+1, y−1/2, −z+1/2; (iv) x−1, y, z. |
Cg1 is the centroid of the C1–C6 benzene ring. |
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1B···O2 | 0.915 (17) | 1.921 (18) | 2.6510 (15) | 135.4 (15) |
N1—H1A···O1i | 0.919 (19) | 1.964 (19) | 2.8824 (15) | 177.8 (17) |
C3—H3···O1ii | 0.93 | 2.616 | 3.546 (2) | 178 |
C4—H4···O1iii | 0.93 | 2.534 | 3.306 (2) | 141 |
C11—H11A···Cg1iv | 0.97 | 2.90 | 3.7283 (16) | 141 |
Symmetry codes: (i) −x, −y+1, −z; (ii) x, −y+1/2, z+1/2; (iii) −x+1, y−1/2, −z+1/2; (iv) x−1, y, z. |
Experimental details
Crystal data | |
Chemical formula | C12H17NO2 |
Mr | 207.27 |
Crystal system, space group | Monoclinic, P21/c |
Temperature (K) | 100 |
a, b, c (Å) | 8.1830 (2), 11.2706 (2), 14.5386 (4) |
β (°) | 119.696 (2) |
V (Å3) | 1164.76 (5) |
Z | 4 |
Radiation type | Cu Kα |
µ (mm−1) | 0.64 |
Crystal size (mm) | 0.25 × 0.19 × 0.10 |
Data collection | |
Diffractometer | SuperNova, Dual, Cu at zero, Atlas diffractometer |
Absorption correction | Multi-scan (CrysAlis PRO; Agilent, 2012) |
Tmin, Tmax | 0.854, 1.000 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 6112, 2268, 1900 |
Rint | 0.022 |
(sin θ/λ)max (Å−1) | 0.621 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.041, 0.115, 1.03 |
No. of reflections | 2268 |
No. of parameters | 145 |
H-atom treatment | H atoms treated by a mixture of independent and constrained refinement |
Δρmax, Δρmin (e Å−3) | 0.19, −0.22 |
Computer programs: CrysAlis PRO (Agilent, 2012), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008) within OLEX2 (Dolomanov et al., 2009), PLATON (Spek, 2009) and Mercury (Macrae et al., 2008), SHELXL97 (Sheldrick, 2008) and PLATON (Spek, 2009).
References
Agilent (2012). CrysAlis PRO. Agilent Technologies, Yarnton, England. Google Scholar
Aitipamula, S., Wong, A. B. H., Chow, P. S. & &Tan, R. B. H. (2012). CrystEngComm, 14, 8515–8524. Web of Science CSD CrossRef CAS Google Scholar
Al Jasem, Y., Hindawi, B. al, Thiemann, T. & White, F. (2012). Acta Cryst. E68, o2639–o2640. CSD CrossRef CAS IUCr Journals Google Scholar
Allen, F. H. (2002). Acta Cryst. B58, 380–388. Web of Science CrossRef CAS IUCr Journals Google Scholar
Back, K. R., Davey, R. J., Grecu, T., Hunter, C. A. & Taylor, L. S. (2012). Cryst. Growth Des. 12, 6110–6117. Web of Science CSD CrossRef CAS Google Scholar
Bavin, E. M., Macrae, F. J., Seymour, D. E. & Waterhouse, P. D. (1952). J. Pharm. Pharmacol. 4, 872–878. CrossRef PubMed CAS Google Scholar
Bodnar, A. L., Cortes-Burgos, L. A., Cook, K. K., Dinh, D. M., Groppi, V. E., Hajos, M., Higdon, N. R., Hoffmann, W. E., Hurst, R. S., Myers, J. K., Rogers, N. B., Wall, T. M., Wolfe, M. L. & Wong, E. (2005). J. Med. Chem. 48, 905–908. Web of Science CrossRef PubMed CAS Google Scholar
Bugenhagen, B., Al Jasem, Y., Barkhad, F., Hindawi, B. al & Thiemann, T. (2012). Acta Cryst. E68, o3169–o3170. Google Scholar
Coates, L. V., Drain, D. J., Kerridge, K. A., Macrae, F. J. & Tattersall, K. (1957). J. Pharm. Pharmacol. 9, 855–862. CrossRef PubMed CAS Google Scholar
Darias, V., Bravo, L., Abdallah, S. S., Sánchez Mateo, C. C., Expósito-Orta, M. A., Lissavetsky, J. & Manzanares, J. (1992). Arch. Pharm. 325, 83–87. CrossRef CAS Web of Science Google Scholar
Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst. 42, 339–341. Web of Science CrossRef CAS IUCr Journals Google Scholar
Florvall, L. & Oegren, S.-O. (1982). J. Med. Chem. 1982, 25, 1280–1286. Google Scholar
Johnstone, R. A. W. & Rose, M. E. (1979). Tetrahedron, 35, 2169–2173. CrossRef CAS Web of Science Google Scholar
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466–470. Web of Science CrossRef CAS IUCr Journals Google Scholar
Macrae, F. J. & Seymour, D. E. (1956). GB 726786 (May 1955) [Herts Pharmaceuticals Ltd.], Chem. Abstr. 50, 28262. Google Scholar
Monkovic, I., Willner, D., Adam, M. A., Brown, M., Crenshaw, R. R., Fuller, C. E., Juby, P. F., Luke, G. M., Matiskella, J. A. & Montzka, T. A. (1988). J. Med. Chem. 31, 1548–1566. CrossRef CAS PubMed Web of Science Google Scholar
Moribe, K., Tsuchiya, M., Tosuka, Y., Yamaguchi, K., Oguchi, T. & Yamamoto, K. (2004). Chem. Pharm. Bull. 52, 524—529. CrossRef Google Scholar
Moribe, K., Tsuchiya, M., Tozuka, Y., Yamaguchi, K., Oguchi, T. & Yamamoto, K. (2006). J. Inclusion Phenom. Macrocycl. Chem. 54, 9–16. Web of Science CSD CrossRef CAS Google Scholar
Pagola, S. & Stephens, P. W. (2009). Acta Cryst. C65, o583–o586. Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Simmonite, D. & Tattersall, K. (1962). GB 872891 (July 1961) [Smith, T. J. & Nephew Ltd.], Chem. Abstr. 56, 18626. Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
Waterbeemd, H. van de & Testa, B. (1983). J. Med. Chem. 26, 203–207. PubMed Web of Science Google Scholar
Wilbrand, S., Neis, C. & Hegetschweiler, K. (2012). Acta Cryst. E68, o3494. CSD CrossRef IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.